Bechmann L P, Manka P, Best J, Saner F H, Paul A, Canbay A, Gerken G
Klinik für Gastroenterologie und Hepatologie, Universitätsklinikum Essen.
Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Universitätsklinikum Essen.
Dtsch Med Wochenschr. 2014 May;139(17):878-82. doi: 10.1055/s-0034-1369932. Epub 2014 Apr 23.
Clinical course and mortality of acute liver failure (ALF) are determined by its causes. Traditionally, fulminant hepatitis B infection (HBV) was thought to be the predominant etiology of ALF in Germany. However, recent studies, conducted in American and European cohorts pointed to drug-induced liver injury (DILI) as the major cause. Aim of this study was to identify currently predominant etiologies of ALF in a monocenter study at a leading transplant center in Germany.
The data of 161 patients admitted with ALF from 1/2002 to 12/2012 were analyzed retrospectively. All patients fulfilled the criteria of the "Acute Liver Failure Study Group Germany" (international normalized ratio (INR) ≥ 1.5, hepatic encephalopathy ≥ stage 1).
DILI was the leading cause of ALF in this cohort. About 20 % of ALF patients with DILI died or received liver transplantats. Mortality rate was highest in ALF patients with unknown etiology and those without specific therapy available.
In Europe ALF etiologies exhibit a North-South divide. In Germany the most common cause for ALF is idiosyncratic pharmacological intoxication followed by acute hepatitis B.
急性肝衰竭(ALF)的临床病程及死亡率取决于其病因。传统上,暴发性乙型肝炎感染(HBV)被认为是德国ALF的主要病因。然而,最近在美国和欧洲队列中进行的研究指出,药物性肝损伤(DILI)是主要病因。本研究的目的是在德国一家领先的移植中心进行的单中心研究中,确定目前ALF的主要病因。
回顾性分析了2002年1月至2012年12月期间收治的161例ALF患者的数据。所有患者均符合“德国急性肝衰竭研究组”的标准(国际标准化比值(INR)≥1.5,肝性脑病≥1期)。
DILI是该队列中ALF的主要病因。约20%的DILI所致ALF患者死亡或接受了肝移植。病因不明且无特效治疗方法的ALF患者死亡率最高。
在欧洲,ALF病因存在南北差异。在德国,ALF最常见的病因是特异质性药物中毒,其次是急性乙型肝炎。